Postmenopausal estrogens and breast cancer

Journal of the Society for Gynecologic Investigation

Volumn 3, Issue 2, 1996, Pages

  Colditz, Graham A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

BODY HEIGHT; BREAST CANCER; CANCER RISK; CHILDBIRTH; ESTROGEN THERAPY; MENARCHE; MENOPAUSE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; BODY HEIGHT; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MATERNAL AGE; MENARCHE; MENOPAUSE; MIDDLE AGED; PARITY; PROGESTINS; RISK FACTORS; UNITED STATES;

EID: 0030028927     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1177/107155769600300202     Document Type: Review

References (48)

1. King M-C, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993; 269:1975-80.
2. Colditz GA, Willett WC, Hunter DJ, et al. Family history, age and risk of breast cancer: Prospective data from the Nurses' Health Study. JAMA 1993;270:338-43.
3. Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H, Nishimori I. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 1987;112:243-72.
4. Tokunaga M, Land CE, Tokuoka S, Nishimori I, Soda M, Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994;138:209-23.
5. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and risk of breast cancer. JAMA 1992;267:941-4.
6. Colditz GA, Willett WC. Epidemiology of breast cancer: Implications for primary prevention. In: Harris JR, ed. Breast disease updates. Philadelphia: JB Lippincott Company, 1992:1-17.
7. Steinberg KK, Thacker SB, Smith SJ, Zack MM, Flanders WD, Berkelman RL. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-90.
8. Sillero-Arenas M, Delgado-Rodriguez M, Rodrigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargus R. Menopausal hormone replacement therapy and breast cancer: A meta-analysis. Obstet Gynecol 1992;79:286-94.
9. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. Am J Obstet Gyn 1993;168:1473-80.
10. Steinberg KK, Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis. Epidemiology 1994;5:415-21.
11. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk ot breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788-95.
12. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274:137-42.
13. Schuurman AG, van den Brandt PA, Goldbohm RA. Exogenous hormone use and the risk of postmenopausal breast cancer: Results from the Netherlands cohort study. Cancer Causes Control 1995;6:416-24.
14. Key TJA, Pike MC. The role of estrogen and progestins in the epidemiology and prevention of breast cancer. Eur J Clin Oncol 1988;24:29-43.
15. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature 1983;303:767-70.
16. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: The Nurses' Health Study. Am J Epidemiol 1994;139:819-35.
17. Russo IH, Russo J. Physiologic bases of breast cancer prevention. Eur J Cancer Prevent 1993;2(suppl):101-11.
18. Lambe M, Hsieh C-c, Trichopoulos D, Ekbom A, Pavia M, Adami H-O. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5-9.
19. Hsieh C, Pavia M, Lambe M, et al. Dual effect of parity on breast cancer risk. Eur J Cancer 1994;30A:969-73.
20. Gray GE, Henderson BE, Pike MC. Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 1980;64: 461-3.
21. US Bureau of Census. Current population reports. Fertility of American women: June 1983. Population characteristics. Series P-20, no. 395.
22. US Bureau of Census. Op cit, table 13.
23. van Weiringen JC. Secular growth changes. In Falkner F, Tanner JM, eds. Human growth: A comprehensive treatise. New York: Plenum Press, 1986:307-32.
24. Chen J, Campbell TC, Junyao L, Peto R. Diet, lifestyle and mortality in China. Oxford, United Kingdom: Oxford University Press, 1990.
25. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993;15:110-32.
26. Vatten LJ, Kvinnsland S. Prospective study of height, body mass index and risk of breast cancer. Acta Oncol 1992;31:195-200.
27. Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer. J Nat Cancer Inst 1972;48:605-13.
28. Gambrell RD Jr, Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progesterone users. Obstet Gynecol 1983;62:435-43.
29. Jurgens RW Jr, Downey LJ, Abernathy WD, Cutler NR, Conrad J. A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy. Am J Obstet Gynecol 1992;167:459-60.
30. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297-302.
31. Colditz GA, Stampfer MJ, Willett WC, et al. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990;264:2648-53.
32. Palmer JR, Rosenberg L, Clarke EA, et al. Breast cancer risk after estrogen replacement therapy: Results from the Toronto Breast Cancer Study. Am J Epidemiol 1991;134:1386-95.
33. Brinton LA, Hoover R, Fraumeni JF. Menopausal oestrogens and breast cancer risk: An expanded case-control study. Br J Cancer 1986;54:825-32.
34. Wingo PA, Layde PM, Lee NC, et al. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 1987;257:209-15.
35. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
36. Gambrell RD. Hormones in the etiology and prevention of breast and endometrial cancer. South Med J 1984;77:1509-15.
37. Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer 1988;42:832-8.
38. Bergkvist L, Adami HO, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293-97.
39. Colditz GA, Stampfer MJ, Willett WC, et al. Type of postmenopausal hormone use and risk of breast cancer: 12-year tollow-up from the Nurses' Health Study. Cancer Causes Control 1992;3: 433-9.
40. Stanford JL, Thomas DB. Exogenous progestins and breast cancer. Epidemiol Rev 1993;15:98-107.
41. Gambrell RD, Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progesterone users. Obstet Gynecol 1983;62:435-43.
42. Kaufman DW, Palmer JR, Demouzon J, et al. Estrogen replacement therapy and risk of breast cancer: Results from case-control surveillance study. Am J Epidemiol 1991;134:1375-85.
43. Yang C, Daling JR, Bard PR, et al. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control 1992;3: 475-9.
44. Felson DT, Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
45. Ettinger B, Grady D. The waning effect of postmenopausal estrogen therapy on osteoporosis (editorial). N Engl J Med 1993; 329:1192-3.
46. Lees B, Molleson T, Arnett TR, Stevenson JC. Differences in proximal femur bone density over two centuries. Lancet 1993; 341:673-5.
47. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of postmenopausal estrogen therapy and cardiovascular disease in women. N Engl J Med 1991;325:756-62.
48. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.